.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,739,073

« Back to Dashboard

Details for Patent: 4,739,073

Title: Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
Abstract:Compounds of the formula ##STR1## wherein one of R and R.sub.o is ##STR2## and the other is primary or secondary C.sub.1-6 alkyl not containing an asymmetric carbon atom, C.sub.3-6 cycloalkyl or phenyl(CH.sub.2).sub.m --, wherein R.sub.4 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.5 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.5a is hydrogen, C.sub.1-2 alkyl, C.sub.1-2 alkoxy, fluoro or chloro, and m is 1, 2 or 3, with the provisos that both R.sub.5 and R.sub.5a must be hydrogen when R.sub.4 is hydrogen, R.sub.5a must be hydrogen when R.sub.5 is hydrogen, not more than one of R.sub.4 and R.sub.5 is trifluoromethyl, not more than one of R.sub.4 and R.sub.5 is phenoxy, and not more than one of R.sub.4 and R.sub.5 is benzyloxy, R.sub.2 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.3-6 cycloalkyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.3 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, with the provisos that R.sub.3 must be hydrogen when R.sub.2 is hydrogen, not more than one of R.sub.2 and R.sub.3 is trifluoromethyl, not more than one of R.sub.2 and R.sub.3 is phenoxy, and not more than one of R.sub.2 and R.sub.3 is benzyloxy, X is --(CH.sub.2).sub.n -- or --CH.dbd.CH--, wherein n is 0, 1, 2 or 3, and Z is ##STR3## wherein R.sub.6 is hydrogen or C.sub.1-3 alkyl, and R.sub.7 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, benzyl or M, wherein M is a pharmaceutically acceptable cation, the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level, and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis, pharmaceutical compositions comprising such compounds and processes for and intermediates in the synthesis of such compounds.
Inventor(s): Kathawala; Faizulla G. (Mountain Lakes, NJ)
Assignee: Sandoz Pharmaceuticals Corp. (E. Hanover, NJ)
Filing Date:Mar 04, 1985
Application Number:06/707,854
Claims:1. A compound of the formula ##STR192## wherein one of R and R.sub.o is ##STR193## and the other is primary or secondary C.sub.1-6 alkyl not having an asymmetric carbon atom, C.sub.3-6 cycloalkyl or phenyl-(CH.sub.2).sub.m --, wherein

R.sub.4 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy,

R.sub.5 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy,

R.sub.5a is hydrogen, C.sub.1-2 alkyl, C.sub.1-2 alkoxy, fluoro or chloro, and

m is 1, 2, or 3, with the provisos that not more than one of R.sub.4 and R.sub.5 is trifluoromethyl, not more than one of R.sub.4 and R.sub.5 is phenoxy and not more than one of R.sub.4 and R.sub.5 is benzyloxy,

R.sub.2 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.3-6 cycloalkyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy,

R.sub.3 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, with the provisos that not more than one of R.sub.2 and R.sub.3 is trifluoromethyl, not more than one of R.sub.2 and R.sub.3 is phenoxy, and not more than one of R.sub.2 and R.sub.3 is benzyloxy,

R.sub.6a is C.sub.1-3 alkyl,

R.sub.7a is C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl or benzyl,

R.sub.11 is C.sub.1-2 alkyl,

R.sub.11a is C.sub.1-3 alkyl, n-butyl or t-butyl,

X is --(CH.sub.2).sub.n -- or --CH.dbd.CH--, wherein n is 0, 1, 2 or 3, and

Y.sup..crclbar. is chloride or bromide.

2. A compound according to claim 1 having the formula ##STR194##

3. The compound according to claim 2 having the formula ##STR195##

4. The compound according to claim 2 having the formula ##STR196##

5. A compound according to claim 1 having the formula ##STR197##

6. A compound according to claim 1 having the formula ##STR198##

7. A compound according to claim 1 having the formula ##STR199##

8. The compound according to claim 7 having the formula ##STR200##

9. A compound according to claim 1 having the formula ##STR201##

10. A compound according to claim 1 having the formula ##STR202##

11. A compound according to claim 10 wherein

R is ##STR203## wherein R.sub.4 ' is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy,

R.sub.5 ' is hydrogen, C.sub.1-2 alkyl, C.sub.1-2 alkoxy, fluoro or chloro, and

R.sub.5a ' is hydrogen or methyl,

R.sub.o is primary or secondary C.sub.1-6 alkyl not having an asymmetric carbon atom,

R.sub.2 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, and

R.sub.3 is hydrogen, C.sub.1-3 alkyl, C.sub.1-2 alkoxy, fluoro or chloro.

12. A compound according to claim 11 wherein

R.sub.o is C.sub.1-3 alkyl,

R.sub.2 is hydrogen, C.sub.1-3 alkyl, methoxy, fluoro, chloro or 4-, 5- or 6-benzyloxy,

R.sub.3 is hydrogen or C.sub.1-3 alkyl,

R.sub.4 ' is hydrogen, methyl, methoxy, fluoro or chloro, R.sub.5 ' is hydrogen, methyl, methoxy, fluoro or chloro, and

R.sub.5a ' is hydrogen or methyl.

13. The compound according to claim 12 having the formula ##STR204##

14. The compound according to claim 12 having the formula ##STR205##

15. A compound according to claim 1 having the formula ##STR206##

16. The compound according to claim 15 having the formula ##STR207##

17. A compound according to claim 1 having the formula ##STR208##

18. A compound according to claim 17 having the formula ##STR209##

19. A compound according to claim 1 having the formula ##STR210##

20. The compound according to claim 19 having the formula ##STR211##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc